Delivery Order SPE2DB25D3002-SPE2DB25FLRLY
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, with a completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a pediatric order from the pharmaceutical distributor's extensive portfolio of federal medical supply contracts. The contract was executed on July 25, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,452.50 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viberzi 75 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award derives from the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg with a ceiling value of $2,122.94 under a firm fixed price contract. This award, issued on September 22, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded, with performance to be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Viberzi 75 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,707.63. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,755.71. This firm fixed-price delivery order, which will be completed by September 9, 2025, carries no set-aside designation and was competitively awarded. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,715.55 for 60 tablets of Viberzi 75 mg, a medication used to treat irritable bowel syndrome. This firm fixed-price delivery order, awarded on August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract was competitively awarded with no...
- This federal contract award, valued at $2,013.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Viberzi 100 mg tablet, with a completion date of May 15, 2025. The contract type is Firm Fixed Price, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The contract, valued at $1,650.57, is for the provision of VIBERZI 100 MG TABLET 60S, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRLYDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,918.41 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract, issued under firm fixed price terms with no set-aside designation, covers the supply of Viberzi 100 mg tablets in a quantity of 60 units, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The contract fulfills DLA's critical medical supply chain requirements, enabling the distribution of pharmaceuticals to support military and veteran healthcare operations. AmerisourceBergen's extensive federal contracting portfolio demonstrates its capability to competitively deliver diverse pharmaceutical products across multiple therapeutic domains through the DLA procurement framework. The award reflects the company's role as a key vendor within the federal medical procurement ecosystem, supporting the Defense Health Agency and other government healthcare systems through flexible contract mechanisms designed to ensure reliable access to essential medications for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/17/25 |